Shares Outstanding Shares Outstanding n/a Close	27.22M
Shares Change (YoY) Shares Change (YoY) n/a Close	-1.66%
Shares Change (QoQ) Shares Change (QoQ) n/a Close	0.31%
Owned by Institutions (%) Owned by Institutions (%) n/a Close	71.03%
Shares Floating Shares Floating n/a Close	22.7M
Failed to Deliver (FTD) Shares Failed to Deliver (FTD) Shares n/a Close	2
FTD / Avg. Volume FTD / Avg. Volume n/a Close	n/a

Short Selling Information

The latest short interest is 1.22M, so 4.36% of the outstanding shares have been sold short.

Short Interest Short Interest n/a Close	1.22M
Short % of Shares Out Short % of Shares Out n/a Close	4.36%
Short % of Float Short % of Float n/a Close	7.04%
Short Ratio (days to cover) Short Ratio (days to cover) n/a Close	3.25

Valuation Ratios

The PE ratio is -5.03 and the forward PE ratio is 23.53. Bio-Rad Laboratories's PEG ratio is -0.03.

PE Ratio PE Ratio n/a Close	-5.03
Forward PE Forward PE n/a Close	23.53
PS Ratio PS Ratio n/a Close	3.61
Forward PS Forward PS n/a Close	2.2
PB Ratio PB Ratio n/a Close	1.41
P/FCF Ratio P/FCF Ratio n/a Close	34.82
PEG Ratio PEG Ratio n/a Close	-0.03

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Bio-Rad Laboratories.

EV / Sales EV / Sales n/a Close	n/a
EV / EBITDA EV / EBITDA n/a Close	n/a
EV / EBIT EV / EBIT n/a Close	n/a
EV / FCF EV / FCF n/a Close	n/a

Financial Position

The company has a current ratio of 6.48, with a Debt / Equity ratio of 0.21.

Current Ratio Current Ratio n/a Close	6.48
Quick Ratio Quick Ratio n/a Close	6.48
Debt / Equity Debt / Equity n/a Close	0.21
Debt / EBITDA Debt / EBITDA n/a Close	-0.65
Debt / FCF Debt / FCF n/a Close	5.16
Interest Coverage Interest Coverage n/a Close	5.5

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity Return on Equity n/a Close	n/a
Return on Assets Return on Assets n/a Close	n/a
Return on Invested Capital Return on Invested Capital n/a Close	n/a
Revenue Per Employee Revenue Per Employee n/a Close	$333,311.69
Profits Per Employee Profits Per Employee n/a Close	$-239,506.49
Employee Count Employee Count n/a Close	7,700
Asset Turnover Asset Turnover n/a Close	0.27
Inventory Turnover Inventory Turnover n/a Close	n/a

Taxes

Income Tax Income Tax n/a Close	-498.3M
Effective Tax Rate Effective Tax Rate n/a Close	21.27%

Stock Price Statistics

The stock price has increased by -21.65% in the last 52 weeks. The beta is 0.94, so Bio-Rad Laboratories's price volatility has been higher than the market average.

Beta Beta n/a Close	0.94
52-Week Price Change 52-Week Price Change n/a Close	-21.65%
50-Day Moving Average 50-Day Moving Average n/a Close	235.88
200-Day Moving Average 200-Day Moving Average n/a Close	299.39
Relative Strength Index (RSI) Relative Strength Index (RSI) n/a Close	50.4
Average Volume (20 Days) Average Volume (20 Days) n/a Close	386,185

Income Statement

In the last 12 months, Bio-Rad Laboratories had revenue of 2.57B and earned -1.84B in profits. Earnings per share was -65.36.

Revenue Revenue n/a Close	2.57B
Gross Profit Gross Profit n/a Close	1.38B
Operating Income Operating Income n/a Close	269M
Net Income Net Income n/a Close	-1.84B
EBITDA EBITDA n/a Close	-2.1B
EBIT EBIT n/a Close	-2.29B
Earnings Per Share (EPS) Earnings Per Share (EPS) n/a Close	-65.36

Full Income Statement

Balance Sheet

The company has 488.1M in cash and 1.37B in debt, giving a net cash position of -886.6M.

Cash & Cash Equivalents Cash & Cash Equivalents n/a Close	488.1M
Total Debt Total Debt n/a Close	1.37B
Net Cash Net Cash n/a Close	-886.6M
Retained Earnings Retained Earnings n/a Close	7.42B
Total Assets Total Assets n/a Close	9.53B
Working Capital Working Capital n/a Close	-503.56M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 455.2M and capital expenditures -189M, giving a free cash flow of 266.2M.

Operating Cash Flow Operating Cash Flow n/a Close	455.2M
Capital Expenditures Capital Expenditures n/a Close	-189M
Free Cash Flow Free Cash Flow n/a Close	266.2M
FCF Per Share FCF Per Share n/a Close	9.44

Full Cash Flow Statement

Margins

Gross margin is 53.73%, with operating and profit margins of 10.48% and -71.86%.

Gross Margin Gross Margin n/a Close	53.73%
Operating Margin Operating Margin n/a Close	10.48%
Pretax Margin Pretax Margin n/a Close	-91.27%
Profit Margin Profit Margin n/a Close	-71.86%
EBITDA Margin EBITDA Margin n/a Close	-81.85%
EBIT Margin EBIT Margin n/a Close	10.48%
FCF Margin FCF Margin n/a Close	10.37%

Dividends & Yields

BIO does not appear to pay any dividends at this time.

Dividend Per Share Dividend Per Share n/a Close	n/a
Dividend Yield Dividend Yield n/a Close	n/a
Dividend Growth (YoY) Dividend Growth (YoY) n/a Close	n/a
Payout Ratio Payout Ratio n/a Close	n/a
Earnings Yield Earnings Yield n/a Close	n/a
FCF Yield FCF Yield n/a Close	n/a

Dividend Details

Analyst Forecast

The average price target for BIO is $330, which is 42.4% higher than the current price. The consensus rating is "Buy".

Price Target Price Target n/a Close	$330
Price Target Difference Price Target Difference n/a Close	42.4%
Analyst Consensus Analyst Consensus n/a Close	Buy
Analyst Count Analyst Count n/a Close	4

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value Lynch Fair Value n/a Close	n/a
Lynch Upside Lynch Upside n/a Close	n/a
Graham Number Graham Number n/a Close	n/a
Graham Upside Graham Upside n/a Close	n/a

Stock Splits

The last stock split was on Mar 8, 2002. It was a forward split with a ratio of 2:1.

Last Split Date Last Split Date n/a Close	Mar 8, 2002
Split Type Split Type n/a Close	forward
Split Ratio Split Ratio n/a Close	2:1

Scores

Altman Z-Score Altman Z-Score n/a Close	0.58
Piotroski F-Score Piotroski F-Score n/a Close	5